Aims to generate 50 Crores revenue by the end of 2021 with this launch.
INDIA: Amway India, one of the country’s leading FMCG direct selling companies, today announced the launch of its Nutrilite Vitamin C Cherry Plus intended for individuals with weakened immunity that comes with the benefit of extended-release technology. With this, Amway India is further strengthening its nutrition and immunity supporting portfolio in the country by introducing a product for special dietary use for individuals with weakened immunity. The Nutrilite Vitamin C Cherry Plus provides steady release of Vitamin C into the body for over 8 hours as it is formulated with Extended-Release technology, to provide all-day immune support.
Commenting on the category, Anshu Budhraja, CEO, Amway India, said, “Today we find ourselves reprioritizing our nutrition and immunity needs as we continue to fight this pandemic while making appropriate lifestyle changes. In the recent times we noticed, health-conscious and individuals with weakened immunity have shifted to preventive and smart healthcare to support their immunity and safeguard themselves. The global health crisis has resulted in a spike in demand for health and nutrition supplements and Vitamin C is one of them as it is known for its immunity supporting properties. Adults Vitamin C market in India was close to 185 Crores in 2020 and is growing with CAGR of 15%. Looking at the growth trend and with the extension of our existing range of products under the nutrition and immunity category, with Nutrilite Vitamin C Cherry Plus targeted for population with specific need we are targeting to generate more than 100 Crores in revenue by 2025.”